CD34 Tissue Distribution: Cells expressing CD34 (CD34+ cell) are normally found in the umbilical cord and bone marrow as hematopoietic cells, or in mesenchymal stem cells, endothelial progenitor cells, endothelial cells of blood vessels but not lymphatics (except pleural lymphatics), mast cells, ...
其所有细胞均不含有HIV-1和乙型肝炎,每个批次细胞均可提供质量分析报告。每支含有≥1,000,000个细胞。 细胞货号:2C-101 中文名称:正常人脐带血CD34+造血干细胞 英文名称:Human Cord Blood CD34+ Stem/Progenitor Cells, Cryopreserved, 1 Million 人脐带血CD34+造血干细胞结合配套的造血细胞培养基,进行无血清培养...
In the present study we extended these observations by examining, in addition to BM derived CD34+ cells, the pattern of chemokine expression in CD34+ cells isolated from i] mobilized peripheral blood (mPB), ii] cord blood (CB) and iii] thymus (Th). We also phenotyped BM, CB, mPB and...
产品信息 货号 名称 规格 价格/元 15126 RosetteSep™ Human Cord Blood Debulking Cocktail/人脐血减积抗体试剂盒 标记40 mL脐血 2596 15166 RosetteSep™ Human Cord Blood Debulking Cocktail/人脐血
Frozen Cell Type Hematopoietic Stem and Progenitor Cells Species Human Cell and Tissue Source Cord Blood Donor Status Normal Purity The purity of CD34+cells is ≥ 90% by flow cytometry. References: 1. "Human PubMed Reference:". https://www.ncbi.nlm.nih.gov/pubmed?linkname=gene_pubmed&from...
Functional CD5+ B cells develop predominantly in the spleen of NOD/SCID/纬cnull (NOG) mice transplanted either with human umbilical cord blood, bone marrow, or mobilized peripheral blood CD34+ cells (2007). “Human cord blood CD34+ cells develop into hepatocytes in the livers of NOD/SCID/ga...
Human cord blood CD34+CD38- cell transduction via lentivirus-based gene transfer vectors. Hum ... J T,Evans,P F,... - 《Human Gene Therapy》 被引量: 236发表: 1999年 Transduction of human CD34+ CD38- bone marrow and cord blood-derived SCID-repopulating cells with third-generation ...
Human umbilical cord blood CD34+ cells were purified using a two-step procedure by elimination of the soybean agglutinin-binding cells and by a positive panning selection with a CD34 monoclonal antibody. The isolated fraction was 88-97% pure CD34+ cells. A yield of 48.5% was obtained when com...
There have been controversies about CD34 and CD38 expression by human cord blood (CB) stem cells. Using the newborn NOD/SCID/β2-microglobulin-null mouse assay that we recently developed, we examined thein vivoengrafting capability of human CB cells. Almost all of the 4–5 months engrafting...
We investigated the phenotypic changes of human umbilical cord blood (CB) CD34+ cells during ex vivo expansion using thrombopoietin (TPO), flt3-ligand (FL), and/or granulocyte-colony stimulating factor (G-CSF). During ex vivo expansion of CD34+ cells isolated from human CB for up to 5 week...